TScan Therapeutics, Inc. (TCRX) News
Track canonical SquawkNews coverage tagged to TCRX, TScan Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
TCRX Reports Q2 2026 Financial Results
TScan Therapeutics reports second quarter 2026 financial results and provides corporate update
EARNINGS | Aug 12, 2026, 11:00 AM UTC
H
TCRX doses first patient
TScan starts Phase 3 trial
EQUITY | Jul 29, 2026, 11:01 AM UTC
M
TCRX: Moves to Phase 3
TScan's cancer therapy data supports move to Phase 3 trial
EQUITY | Jun 22, 2026, 11:10 AM UTC
H
TCRX: Reports Positive Data
TScan Therapeutics announces positive initial data from cohort C of ongoing ALLOHA Phase 1 study evaluating TSC-101
EQUITY | Jun 22, 2026, 11:00 AM UTC